1010-90-8 Usage
General Description
3-Butyl-6-methyl-2,4(1H,3H)-pyrimidinedione, also known as oryzalin, is a chemical compound commonly used as a herbicide and plant growth regulator. It works by disrupting the formation of microtubules in plant cells, leading to cell division and growth inhibition. Oryzalin is effective in controlling a wide range of grassy and broadleaf weeds, making it a popular choice for weed control in agricultural and horticultural settings. However, it is important to use this chemical with caution, as it can be harmful to non-target plants and animals and may have detrimental effects on the environment if not used properly. Oryzalin is also known to have low toxicity to humans, but exposure to high levels of the chemical can cause irritation to the eyes, skin, and respiratory system.
Check Digit Verification of cas no
The CAS Registry Mumber 1010-90-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,1 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1010-90:
(6*1)+(5*0)+(4*1)+(3*0)+(2*9)+(1*0)=28
28 % 10 = 8
So 1010-90-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H14N2O2/c1-3-4-5-11-8(12)6-7(2)10-9(11)13/h6H,3-5H2,1-2H3,(H,10,13)
1010-90-8Relevant articles and documents
A2B ADENOSINE RECEPTOR ANTAGONISTS
-
Page/Page column 34, (2008/06/13)
Disclosed are novel compounds that are A2B adenosine receptor antagonists having the following structure (I) wherein R1 and R2 are independently chosen from hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl, and R4 is an optionally substituted heteroaryl moiety. The compounds of the invention are useful for treating various disease states, including asthma, chronic obstructive pulmonary disorder, pulmonary inflammation, emphysema, diabetic disorders, inflammatory gastrointestinal tract disorders, immunological/inflammatory disorders, cardiovascular diseases, neurological disorders, and diseases related to angiogenesis.
